
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.


SEEK ID: https://cgnbonn.fdm.digital-medicine.org/publications/10
PubMed ID: 27540135
Trial Projects: Randomised phase III trial for previously untreated multiple myeloma to ...
Publication type: Journal
Journal: Haematologica
Citation: Haematologica. 2016 Dec;101(12):e485-e487. doi: 10.3324/haematol.2016.151266. Epub 2016 Aug 18.
Date Published: 20th Aug 2016
Registered Mode: by PubMed ID

Views: 139
Created: 5th Nov 2024 at 16:18

This item has not yet been tagged.

None